Article
Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases.
Blood cancer journal - 2 Nov 2022
Reichard Kaaren K, Tefferi Ayalew, Abdelmagid Maymona, Orazi Attilio, Alexandres Christina, Haack Joanna, Greipp Patricia T
Abstract excerpt
Pure erythroid leukemia (PEL), also known as acute erythroid leukemia (AEL), is recognized as a distinct morphologic entity by both the 2016 and 2022 World Health Organization (WHO) classification system. By contrast, the 2022 International Consensus Classification (ICC) includes PEL under a broader category of "acute myeloid leukemia with mutated TP53". We identified 41 Mayo Clinic cases of PEL (mean age 66...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
